Publication | Open Access
Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer
43
Citations
27
References
2019
Year
Patients with intermediate- and high-risk DTC might not benefit from thyrotropin suppression. This study provides the justification for a randomized trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1